Skip to content

AI prescriptions: App to issue drugs without doctors’ oversight in the US

Utah has become the first state in the US to allow artificial intelligence to issue new prescriptions and will soon do so without any initial medical involvement.

US healthcare startup Nolla Health was authorised by the state to prescribe acne drugs earlier this month.

The authorisation allows Nolla’s AI to prescribe drugs to adults in Utah who have mild to moderate acne after they have submitted their facial scans and medical information for the algorithm to review through the company’s Nolla Derm app.

While every prescription will initially require a doctor’s approval, the AI will issue drugs independently in later phases of the trial.

A company spokesperson told The BMJ, “Nolla remains in phase 1, requiring two Utah licensed doctors to review every prescription before it is issued.

“The agreement lays out performance requirements and safeguards that must be met before we would consider progression to later phases.”

The spokesperson added, “Nolla retains liability for its operations, participating doctors remain subject to applicable professional obligations, and patients retain their traditional legal remedies. The agreement with the state government requires adverse event reporting, immediate pauses for serious safety incidents, and ongoing state oversight.

“Our office retains authority to terminate the pilot.”

Read full story

Source: BMJ, 19 October 2026

User Feedback

Recommended Comments

There are no comments to display.

Create an account or sign in to comment

Registered address: Patient Safety Learning, China Works SB203, 100 Black Prince Road Vauxhall, London, SE1 7SJ

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.